Human genetics and pharmacology of neurotransmitter transporters

Handbook of Experimental Pharmacology

Volumn 175, Issue , 2006, Pages 327-371

  Lin, Z ^a   Madras, B K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Dopamine transporter; Norepinephrine transporter; Serotonin transporter; Single nucleotide polymorphisms; Transporter pharmacology

Indexed keywords

DOPAMINE TRANSPORTER; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; SLC6A2 PROTEIN, HUMAN; SLC6A3 PROTEIN, HUMAN; SLC6A4 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANIMAL; ATTENTION DEFICIT DISORDER; BRAIN; CHEMISTRY; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MAJOR DEPRESSION; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; PSYCHOSIS; REVIEW; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; DEPRESSIVE DISORDER, MAJOR; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PSYCHOSES, SUBSTANCE-INDUCED; SEQUENCE ALIGNMENT; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 34147209908     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-29784-7_16     Document Type: Article

References (218)

1. Anderson GM,HorneWC(1992)Activators of protein kinaseCdecrease serotonin transport in human platelets. Biochim Biophys Acta 1137:331-337
2. Anguelova M, Benkelfat C, Turecki G (2003) A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 8:646-653
3. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD (1998) Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther 287:733-743
4. ArangoV,UnderwoodMD,BoldriniM,Tamir H,Kassir SA, HsiungS,ChenJJ,MannJJ (2001) Serotonin 1A receptors, serotonin transporter binding and serotonin transportermRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25:892-903
5. Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG (2004) Interacting effects of genetic predisposition and depression on adolescent smoking progression.Am J Psychiatry 161:1224-1230
6. Baca-Garcia E, Vaquero C, Diaz-Sastre C, Garcia-Resa E, Saiz-Ruiz J, Fernandez-Piqueras J, de Leon J (2004) Lack of association between the serotonin transporter promoter gene polymorphism and impulsivity or aggressive behavior among suicide attempters and healthy volunteers. Psychiatry Res 126:99-106
7. Barr CL, Xu C, Kroft J, Feng Y,Wigg K, Zai G, Tannock R, Schachar R,Malone M, RobertsW, Nothen MM, Grunhage F, Vandenbergh DJ, Uhl G, Sunohara G, King N, Kennedy JL (2001) Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry 49:333-339
8. Bastani B, Arora RC, Meltzer HY (1991) Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biol Psychiatry 30:131-139
9. Battersby S,OgilvieAD, Smith CA, Blackwood DH,MuirWJ,Quinn JP, FinkG,GoodwinGM, Harmar AJ (1996) Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr Genet 6:177-181
10. Battersby S, Ogilvie AD, Blackwood DH, Shen S, Muqit MM, Muir WJ, Teague P, Goodwin GM, Harmar AJ (1999) Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3 untranslated region of the human serotonin transporter gene. J Neurochem 72:1384-1388
11. Belfer I, Phillips G, Taubman J, Hipp H, Lipsky RH, Enoch MA, Max MB, Goldman D (2004) Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations. J Hum Genet 49:232-245
12. Bellini M, Rappelli L, Blandizzi C, Costa F, Stasi C, Colucci R, Giannaccini G, Marazziti D, Betti L, Baroni S, Mumolo MG, Marchi S, Del Tacca M (2003) Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am J Gastroenterol 98:2705-2711
13. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, LeschKP(1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (Ecstasy) in serotonin transporter-deficient mice. Mol Pharmacol 53:649-655
14. Billett EA, RichterMA, King N, Heils A, Lesch KP, Kennedy JL (1997) Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 2:403-406
15. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ (1998) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44:169-178
16. Blum K, Braverman ER, Wu S, Cull JG, Chen TJ, Gill J, Wood R, Eisenberg A, Sherman M, Davis KR, Matthews D, Fischer L, Schnautz N,WalshW, Pontius AA, Zedar M, Kaats G, Comings DE (1997) Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry 2:239-246
17. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, Clasen LS, SharpWS, Inoff-Germain G,Wavrant-DeVrieze F, Arcos-Burgos M, Straub RE,Hardy JA, Castellanos FX, Rapoport JL (2005a) Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 134:67-72
18. Bobb AJ, Castellanos FX, Addington AM, Rapoport JL (2005b)Molecular genetic studies of ADHD: 1991 to 2004. Am J Med Genet B Neuropsychiatr Genet 132:109-125
19. Bohm M, La Rosee K, Schwinger RH, Erdmann E (1995) Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25:146-153
20. Bosse R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG (1997) Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19:127-138
21. Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, Hansson SR (2004) Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 25:518-529
22. Cadoret RJ, Langbehn D, Caspers K, Troughton EP, Yucuis R, SandhuHK, Philibert R (2003) Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population. Compr Psychiatry 44:88-101
23. Chen CK, Chen SL, Mill J, Huang YS, Lin SK, Curran S, Purcell S, Sham P, Asherson P (2003) The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry 8:393-396
24. Chen WJ, Chen CH, Huang J, Hsu YP, Seow SV, Chen CC, Cheng AT (2001) Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and Han Chinese in Taiwan. Psychiatr Genet 11:187-195
25. Cho HJ, Meira-Lima I, Cordeiro Q, Michelon L, Sham P, Vallada H, Collier DA (2005) Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry 10:771-781
26. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723
27. Comings DE,Wu S, Chiu C, Ring RH, Gade R, Ahn C,MacMurray JP, Dietz G,Muhleman D (1996) Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes-DRD2,DbetaH, andDAT1. AmJMed Genet 67:264-288
28. Conroy J,Meally E,Kearney G, FitzgeraldM,GillM,GallagherL(2004) Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 9:587-593
29. Contin M, Martinelli P, Mochi M, Albani F, Riva R, Scaglione C, Dondi M, Fanti S, Pettinato C, BaruzziA (2004) Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. Clin Neuropharmacol 27:111-115
30. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998
31. Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A, Haas R, Courchesne E, Leventhal BL (1997) Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2:247-250
32. Courtet P, Baud P, Abbar M, Boulenger JP, Castelnau D, Mouthon D, Malafosse A, Buresi C (2001) Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Mol Psychiatry 6:338-341
33. CurranS,Mill J,TahirE,KentL,RichardsS,GouldA,HuckettL, SharpJ,BattenC,FernandoS, Ozbay F, Yazgan Y, Simonoff E, Thompson M, Taylor E, Asherson P (2001) Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6:425-428
34. Curran S, Purcell S, Craig I, Asherson P, Sham P (2005) The serotonin transporter gene as a QTL for ADHD. Am J Med Genet B Neuropsychiatr Genet 134:42-47
35. Daniels GM, Amara SG (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794-35801
36. Davidge KM, Atkinson L, Douglas L, Lee V, Shapiro S, Kennedy JL, Beitchman JH (2004) Association of the serotonin transporter and 5HT1Dbeta receptor genes with extreme, persistent and pervasive aggressive behaviour in children. Psychiatr Genet 14:143-146
37. Daws LC, CallaghanPD,Moron JA,KahligKM, ShippenbergTS, Javitch JA, GalliA(2002)Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290:1545-1550
38. De La Garza R 2nd, Madras BK (2000) [(3)H]PNU-101958, a D(4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain. Synapse 37:232-244
39. De LucaV,Muglia P, JainU,Kennedy JL (2004)No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD. Am J Med Genet B Neuropsychiatr Genet 124:38-40
40. Delbruck SJ, Wendel B, Grunewald I, Sander T, Morris-Rosendahl D, Crocq MA, Berrettini WH, Hoehe MR (1997) A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. Cytogenet Cell Genet 79:214-220
41. Delbruck SJ, Kidd KU, Hoehe MR(2001) Identification of an additional allelic variant (XLS) of the human serotonin transporter gene (SLC6A4): -1201Cins66. Hum Mutat 17:524
42. Di Bella D, Catalano M, Balling U, Smeraldi E, Lesch KP (1996) Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE. Am J Med Genet 67:541-545
43. Dobashi I, Inada T,HadanoK(1997) Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population. Psychiatr Genet 7:87-91
44. Doucette-Stamm LA, Blakely DJ, Tian J, Mockus S, Mao JI (1995) Population genetic study of the human dopamine transporter gene (DAT1). Genet Epidemiol 12:303-308
45. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S (2001) Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108:1141-1150
46. Eddahibi S, Chaouat A,Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, Adnot S (2003) Polymorphism of the serotonin transporter geneandpulmonaryhypertensioninchronicobstructivepulmonary disease. Circulation 108:1839-1844
47. Erblich J, Lerman C, SelfDW,Diaz GA, BovbjergDH(2004) Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J 4:102-109
48. Eshleman AJ, Stewart E, Evenson AK, Mason JN, Blakely RD, Janowsky A, Neve KA (1997) Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J Neurochem 69:1459-1466
49. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P (1981) Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension 3:149-156
50. Falkenburger BH, BarstowKL,Mintz IM(2001) Dendrodendritic inhibitionthrough reversal of dopamine transport. Science 293:2465-2470
51. Fan JB, Sklar P (2005)Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 10:928-938, 891
52. Feinn R, Nellissery M, Kranzler HR (2005) Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 133:79-84
53. Fischman AJ, Madras BK (2005) The neurobiology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 57:1374-1376
54. Fiskerstrand CE, Lovejoy EA, Quinn JP (1999) An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 458:171-174
55. Flattem NL, Blakely RD (2000) Modified structure of the human serotonin transporter promoter. Mol Psychiatry 5:110-115
56. Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GR (1999) Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol 382:45-49
57. Franke P, Schwab SG, Knapp M, Gansicke M, Delmo C, Zill P, Trixler M, Lichtermann D, Hallmayer J,Wildenauer DB, Maier W(1999) DAT1 gene polymorphism in alcoholism: a family-based association study. Biol Psychiatry 45:652-654
58. FrankleWG,Narendran R,Huang Y, HwangDR, Lombardo I, Cangiano C, Gil R, Laruelle M, Abi-Dargham A (2005) Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB. Biol Psychiatry 57:1510-1516
59. Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, Fuchs C, Zohar J, Lerer B, Buniak SF, Landa S, Poyurovsky M, Shapira B, Weizman R (2000) Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 10:205-209
60. Fumeron F, Betoulle D, Aubert R, Herbeth B, Siest G, Rigaud D (2001) Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol Psychiatry 6:9-10
61. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, Easton DF, Rubinsztein DC (1998) Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 81:58-63
62. Gainetdinov RR, Caron MG (2003)Monoamine transporters: fromgenes to behavior. Annu Rev Pharmacol Toxicol 43:261-284
63. Galeeva AR, Iurev EB, Khusnutdinova EK (2001) [The evaluation of VNTR-polymorphism in the gene of dopamine transporter in men of different nationalitieswith acute alcoholic psychosis]. Zh Nevrol Psikhiatr Im S S Korsakova 101:43-45
64. Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, Kim KS, Biaggioni I, Shannon JR, Blakely RD, Robertson D (2002) Genetic basis of clinical catecholamine disorders. Ann N Y Acad Sci 971:506-514
65. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M (2001) Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 115:358-364
66. Gelernter J, Kranzler HR, Satel SL, Rao PA (1994) Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11:195-200
67. Gelernter J, Kranzler H, Cubells JF (1997) Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria inAfrican- andEuropean-American and Japanese populations and in alcohol-dependent subjects. Hum Genet 101:243-246
68. Gerra G, Garofano L, Zaimovic A, Moi G, Branchi B, Bussandri M, Brambilla F, Donnini C (2005) Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am J Med Genet B Neuropsychiatr Genet 135:73-78
69. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M (1997) Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.Mol Psychiatry 2:311-313
70. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612
71. Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH, Risch N, Freimer NB (2001) Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet 27:435-438
72. Gorwood P, Limosin F, Batel P,HamonM,Ades J, BoniC(2003) The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol Psychiatry 53:85-92
73. Gorwood P, Lanfumey L, Hamon M (2004) [Alcohol dependence and polymorphisms of serotonin-related genes]. Med Sci (Paris) 20:1132-1138
74. Greenwood TA, Kelsoe JR (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-520
75. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR (2001) Evidence for linkage disequilibriumbetween the dopamine transporter and bipolar disorder. Am J Med Genet 105:145-151
76. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Shaw SH, Kelsoe JR (2002) Segmental linkage disequilibrium within the dopamine transporter gene. Mol Psychiatry 7:165-173
77. Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M, Borrmann-Hassenbach M, Knapp M, Cichon S, Maier W, Rietschel M, Propping P, Nothen MM (2000) Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 5:275-282
78. Gulley JM, Zahniser NR (2003) Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479:139-152
79. Hahn MK, Robertson D, Blakely RD (2003) Amutation in the human norepinephrine transporter gene (SLC6A2) associatedwith orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci 23:4470-4478
80. Hahn MK, Mazei-Robison MS, Blakely RD (2005) Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol 68:457-466
81. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A (1999) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247
82. Han DH, Park DB, Na C, Kee BS, Lee YS (2004) Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes. Psychiatry Res 129:29-37
83. HaririAR,MattayVS,TessitoreA,KolachanaB,FeraF,GoldmanD, EganMF,WeinbergerDR (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403
84. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
85. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133-139
86. Hernandez I, Sokolov BP (1997) Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics. Mol Psychiatry 2:57-64
87. Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211-227
88. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, Harrington R,McGuffin P,Owen M, OllierW,Worthington J, ThaparA(2000)Afamily- based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 5:523-530
89. Hong CJ, Cheng CY, Shu LR, Yang CY, Tsai SJ (2003) Association study of the dopamine and serotonin transporter genetic polymorphisms and methamphetamine abuse in Chinese males. J Neural Transm 110:345-351
90. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, SchuckitMA(2005) An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 29:8-16
91. Ingram SL, Prasad BM, Amara SG (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5:971-978
92. Inoue K, Itoh K, Yoshida K, Shimizu T, Suzuki T (2004) Positive association between T- 182C polymorphism in the norepinephrine transporter gene and susceptibility tomajor depressive disorder in a Japanese population. Neuropsychobiology 50:301-304
93. Iwasa H, Kurabayashi M, Nagai R, Nakamura Y, Tanaka T (2001) Genetic variations in five genes involved in the excitement of cardiomyocytes. J Hum Genet 46:549-552
94. Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165-229
95. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J (2000) Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 157:1700-1703
96. JavorsMA,SeneviratneC,Roache JD,Ait-Daoud N,Bergeson SE,Walss-BassMC, Akhtar FZ, Johnson BA (2005) Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Prog Neuropsychopharmacol Biol Psychiatry 29:7-13
97. JormAF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, Tan X, Easteal S (2000) Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. Am J Med Genet 96:331-334
98. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L (2005) Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers andmotor hyperactivity. Biol Psychiatry 57:229-238
99. Keikhaee MR, Fadai F, Sargolzaee MR, Javanbakht A, Najmabadi H, Ohadi M (2005) Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 135:47-49
100. Kennelly PJ, Krebs EG (1991) Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol Chem 266:15555-15558
101. Khodayari N, Garshasbi M, Fadai F, Rahimi A, Hafizi L, Ebrahimi A, Najmabadi H, OhadiM (2004) Association of the dopamine transporter gene (DAT1) core promoter polymorphism ?67T variant with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 129:10-12
102. Kilic F, Murphy DL, Rudnick G (2003) A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64:440-446
103. Kim CH, Kim HS, Cubells JF, Kim KS (1999) A previously undescribed intron and extensive 5 upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J Biol Chem 274:6507-6518
104. Kimmel HL, Carroll FI, Kuhar MJ (2000) Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76. Neuropharmacology 39:578-585
105. Kinnear CJ, Niehaus DJ, Moolman-Smook JC, du Toit PL, van Kradenberg J, Weyers JB, Potgieter A, Marais V, Emsley RA, Knowles JA, Corfield VA, Brink PA, Stein DJ (2000) Obsessive-compulsive disorder and the promoter region polymorphism(5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. Int J Neuropsychopharmacol 3:327-331
106. Kirley A, Lowe N, Hawi Z, Mullins C, Daly G, Waldman I, McCarron M, ODonnell D, Fitzgerald M, Gill M (2003) Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet 121:50-54
107. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A (1997) Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 6:2233-2238
108. KlenovaE, ScottAC, Roberts J, ShamsuddinS, LovejoyEA, BergmannS, BubbVJ,RoyerHD, Quinn JP (2004) YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders. J Neurosci 24:5966-5973
109. Klimek V, Stockmeier C, Overholser J,Meltzer HY, Kalka S, Dilley G, Ordway GA (1997) Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17:8451-8458
110. Kremer I, Bachner-MelmanR,Reshef A, Broude L,Nemanov L,Gritsenko I,Heresco-LevyU, Elizur Y, Ebstein RP (2005) Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry 162:924-930
111. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT (2005) Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet 133:110-115
112. Lee DY, Park H, Kim WH, Lee SI, Seo YJ, Choi YC (2004) [Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome]. Korean J Gastroenterol 43:18-22
113. Lerman C, Caporaso NE, Audrain J,Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG (1999) Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 18:14-20
114. Lerman C, Shields PG,Wileyto EP, Audrain J, Hawk LH Jr, Pinto A, Kucharski S, Krishnan S, Niaura R, Epstein LH (2003) Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol 22:541-548
115. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, HamerDH,MurphyDL (1996)Association of anxiety-related traitswith a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
116. Leszczynska-Rodziewicz A, Czerski PM, Kapelski P, Godlewski S, Dmitrzak-Weglarz M, Rybakowski J, Hauser J (2002) A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association. Neuropsychobiology 45:182-185
117. Levinson DF (2005) Meta-analysis in psychiatric genetics. Curr Psychiatry Rep 7:143-151
118. Li LB, Chen N, Ramamoorthy S, Chi L, Cui XN, Wang LC, Reith ME (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem 279:21012-21020
119. Li T, Holmes C, Sham PC, Vallada H, Birkett J, Kirov G, Lesch KP, Powell J, Lovestone S, Collier D (1997) Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimers disease. Neuroreport 8:683-686
120. Limosin F, Loze JY, Boni C, Fedeli LP, Hamon M, Rouillon F, Ades J, Gorwood P (2004) The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neurosci Lett 362:91-94
121. Lin PY, Tsai G (2004) Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 55:1023-1030
122. Lin Z, Uhl GR (2003)Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities. Pharmacogenomics J 3:159-168
123. Lin Z,WangW,Kopajtic T, Revay RS, Uhl GR(1999) Dopamine transporter: transmembrane phenylalaninemutations can selectively influence dopamine uptake and cocaine analog recognition. Mol Pharmacol 56:434-447
124. Ling D, Niu T, Feng Y, Xing H, Xu X (2004) Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence. J Hum Genet 49:35-39
125. LittleKY,McLaughlinDP, Zhang L,Livermore CS, DalackGW,McFintonPR, DelPropostoZS, Hill E, Cassin BJ,Watson SJ, Cook EH (1998) Cocaine, ethanol, and genotype effects on humanmidbrain serotonin transporter binding sites andmRNA levels. Am J Psychiatry 155:207-213
126. Little KY, Zhang L, Desmond T, Frey KA, DalackGW, Cassin BJ (1999) Striatal dopaminergic abnormalities in human cocaine users. Am J Psychiatry 156:238-245
127. Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L (2002) Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61:436-445
128. Loder MK, Melikian HE (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278:22168-22174
129. Lotrich FE, Pollock BG (2004) Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet 14:121-129
130. MacKenzie A, Quinn J (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A 96:15251-15255
131. Madras BK, Miller GM, Fischman AJ (2002) The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behav Brain Res 130:57-63
132. Madras BK, Miller GM, Fischman AJ (2005) The dopamine transporter and attentiondeficit/ hyperactivity disorder. Biol Psychiatry 57:1397-1409
133. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM (2002) Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 12:207-215
134. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, OwensMJ,NemeroffCB, Rajeevan N, BaldwinRM, Seibyl JP, InnisRB, CharneyDS(1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 44:1090-1098
135. Mao W, Qin F, Iwai C, Vulapalli R, Keng PC, Liang CS (2004) Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells.AmJ Physiol Heart Circ Physiol 287:H29-39
136. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M (2001) The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associatedwith significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24:553-560
137. Matsushita S, Suzuki K, Murayama M, Nishiguchi N, Hishimoto A, Takeda A, Shirakawa O, Higuchi S (2004) Serotonin transporter regulatory region polymorphism is associated with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 128:114-117
138. McConathy J, OwensMJ, Kilts CD, Malveaux EJ, Camp VM,Votaw JR,Nemeroff CB, Goodman MM (2004) Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter. Nucl Med Biol 31:705-718
139. McDougle CJ, Epperson CN, Price LH, Gelernter J (1998) Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 3:270-273
140. McEvoy B, Hawi Z, Fitzgerald M, Gill M (2002) No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am J Med Genet 114:665-666
141. Merlet P, Dubois-Rande JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, Valette H, Castaigne A, Syrota A (1992) Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 19:10-16
142. Mill J, Asherson P, Browes C, DSouza U, Craig I (2002) Expression of the dopamine transporter gene is regulated by the 3 UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114:975-979
143. Miller GM, Madras BK (2002) Polymorphisms in the 3-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7:44-55
144. Miller KJ,Hoffman BJ (1994) Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J Biol Chem 269:27351-27356
145. Miranda M, Wu CC, Sorkina T, Korstjens D, Sorkin A (2005) Enhanced
146. Mortensen OV, Amara SG (2003) Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479:159-170
147. Muglia P, Jain U, Inkster B, Kennedy JL (2002) A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD. Neuropsychopharmacology 27:655-662
148. Muller-Vahl KR, Berding G, Brucke T, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, Knapp WH, Emrich HM (2000) Dopamine transporter binding in Gilles de la Tourette syndrome. J Neurol 247:514-520
149. MunafoMR, Clark T, Flint J (2005) Does measurement instrumentmoderate the association between the serotonin transporter gene and anxiety-related personality traits? A metaanalysis. Mol Psychiatry 10:415-419
150. Muramatsu T,Higuchi S (1995) Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun 211:28-32
151. Myers CL, Pitt BR (1988) Selective effect of phorbol ester on serotonin removal and ACE activity in rabbit lungs. J Appl Physiol 65:377-384
152. NakamuraM,UenoS,SanoA,TanabeH(2000)Thehumanserotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5:32-38
153. Nakatome M,Honda K, Islam MN, Terada M, Yamazaki M, Kuroki H, Ogura Y, Bai H,Wakasugi C (1995) Amplification of DAT1 (human dopamine transporter gene) 3 variable region in the Japanese population. Hum Hered 45:262-265
154. Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, Alavi A (2005) 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med 46:973-977
155. Newport DJ, Owens MJ, Knight DL, Ragan K, Morgan N, Nemeroff CB, Stowe ZN (2004) Alterations in platelet serotonin transporter binding in women with postpartum onset major depression. J Psychiatr Res 38:467-473
156. Nirenberg MJ,Vaughan RA, UhlGR,Kuhar MJ, PickelVM(1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436-447
157. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347:731-733
158. Oh KS, Shin DW, Oh GT, Noh KS (2003) Dopamine transporter genotype influences the attention deficit in Korean boys with ADHD. Yonsei Med J 44:787-792
159. Ono K, Iwanaga Y, Mannami T, Kokubo Y, Tomoike H, Komamura K, Shioji K, Yasui N, Tago N, Iwai N (2003) Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertens Res 26:685-689
160. Owen D, Du L, Bakish D, Lapierre YD, Hrdina PD (1999) Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res 87:1-5
161. OwensMJ, Nemeroff CB (1998) The serotonin transporter and depression. Depress Anxiety 8 Suppl 1:5-12
162. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL (2003) Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8:895, 933-936
163. Pata C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O (2002) Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 97:1780-1784
164. Patkar AA, Berrettini WH, Hoehe M, Thornton CC, Gottheil E, Hill K,Weinstein SP (2002) Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals. Psychiatry Res 110:103-115
165. Patkar AA, Gopalakrishnan R, Berrettini WH, Weinstein SP, Vergare MJ, Leone FT (2003) Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers. Psychopharmacology (Berl) 166:221-227
166. Paul SM, Rehavi M, Skolnick P, Ballenger JC, Goodwin FK (1981) Depressed patients have decreased binding of tritiated imipramine to platelet serotonin transporter. Arch Gen Psychiatry 38:1315-1317
167. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, Harrington R,McGuffin P, ODonovan M, Owen M, Ollier W, Worthington J, Thapar A (2001a) Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet 105:464-470
168. Payton A, Holmes J, Barrett JH, Sham P, Harrington R, McGuffin P, Owen M, Ollier W, Worthington J, Thapar A (2001b) Susceptibility genes for a trait measure of attention deficit hyperactivity disorder: a pilot study in a non-clinical sample of twins. Psychiatry Res 105:273-278
169. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8:828-834
170. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD (2005) Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci U S A 102:11545-11550
171. Qian Q, Wang Y, Li J, Yang L, Wang B, Zhou R (2003) [Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder]. Beijing Da Xue Xue Bao 35:412-418
172. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57
173. Retz W, Retz-Junginger P, Supprian T, Thome J, Rosler M (2004) Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav Sci Law 22:415-425
174. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH (2001) Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 105:471-478
175. Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz MH (2002) Dopamine transporter gene and response tomethylphenidate in attention-deficit/ hyperactivity disorder. Pharmacogenetics 12:497-499
176. RoweDC, Stever C, Gard JM, Cleveland HH, SandersML,Abramowitz A,Kozol ST,Mohr JH, Sherman SL,Waldman ID (1998) The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav Genet 28:215-225
177. Rowe DC, Stever C, Chase D, Sherman S, Abramowitz A,Waldman ID (2001) Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatry 6:429-433
178. Runkel F, Bruss M, Nothen MM, Stober G, Propping P, Bonisch H (2000) Pharmacological properties of naturally occurring variants of the human norepinephrine transporter. Pharmacogenetics 10:397-405
179. Ryu SH, Lee SH, Lee HJ, Cha JH, Ham BJ, Han CS, Choi MJ, Lee MS (2004) Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology 49:174-177
180. Sand PG,MoriT,GodauC, StoberG, Flachenecker P, Franke P,NothenMM,Fritze J,MaierW, Lesch KP, Riederer P, Beckmann H, Deckert J (2002) Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Lett 333:41-44
181. SanderT,HarmsH, Podschus J, FinckhU, Nickel B, RolfsA,RommelspacherH, Schmidt LG (1997) Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 41:299-304
182. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitivemechanism. ProcNatlAcad Sci U S A 97:6850-6855
183. Schinka JA, Busch RM, Robichaux-Keene N (2004) A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety.Mol Psychiatry 9:197-202
184. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T (1998) Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 155:474-478
185. Sen S, Burmeister M, Ghosh D (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism(5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127:85-89
186. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrinetransporter deficiency. N Engl J Med 342:541-549
187. SondersMS, Zhu SJ, Zahniser NR, KavanaughMP, Amara SG (1997)Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960-974
188. Sora I,WichemsC,Takahashi N, LiXF,Zeng Z,RevayR, LeschKP,Murphy DL, UhlGR(1998) Cocaine reward models: conditioned place preference can be established in dopamineand in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A 95:7699-7704
189. Sora I, Hall FS, Andrews AM, ItokawaM, Li XF,Wei HB,Wichems C, Lesch KP,Murphy DL, Uhl GR (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A 98:5300-5305
190. SorkinaT,Doolen S, Galperin E,ZahniserNR, SorkinA(2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J Biol Chem 278:28274-28283
191. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, KnappM, Beckmann H, Propping P (1996) Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 67:523-532
192. Stober G, Hebebrand J, Cichon S, Bruss M, Bonisch H, Lehmkuhl G, Poustka F, Schmidt M, Remschmidt H, Propping P, Nothen MM (1999) Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening. Am J Med Genet 88:158-163
193. Sundaramurthy D, Pieri LF, Gape H, Markham AF, Campbell DA (2000) Analysis of the serotonin transporter gene linked polymorphism (5-HTTLPR) in anorexia nervosa. Am J Med Genet 96:53-55
194. Szot P, Leverenz JB, Peskind ER, Kiyasu E, Rohde K, Miller MA, RaskindMA(2000) Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimers disease. Brain Res Mol Brain Res 84:135-140
195. Todd RD, Jong YJ, Lobos EA, Reich W, Heath AC, Neuman RJ (2001) No association of the dopamine transporter gene 3 VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet 105:745-748
196. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD, Caron MG (2003) Oligomerizationandtraffickingof thehumandopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278:2731-2739
197. Tsai SJ,Wang YC, Hong CJ (2002) Norepinephrine transporter and alpha(2c) adrenoceptor allelic variants and personality factors. Am J Med Genet 114:649-651
198. Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T, Komiyama T, Mitsushio H, Sano A, TanabeH(1999) Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism.Mol Psychiatry 4:552-557
199. Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, Sora I, Iyo M, Katsu T, Nomura A, Nakata K, Ozaki N (2003) Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J 3:242-247
200. Urwin RE, Bennetts B,Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn KP (2002) Anorexia nervosa (restrictive subtype) is associated with a polymorphismin the novel norepinephrine transporter gene promoter polymorphic region.Mol Psychiatry 7:652-657
201. van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB (2000) Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT. Neurobiol Aging 21:497-501
202. van Dyck CH, Malison RT, Staley JK, Jacobsen LK, Seibyl JP, Laruelle M, Baldwin RM, Innis RB, Gelernter J (2004) Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry 161:525-531
203. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J (2005) Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46:745-751
204. VandenberghDJ, Persico AM,Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992)Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106
205. VandenberghDJ, ThompsonMD, Cook EH, Bendahhou E,Nguyen T, KrasowskiMD, ZarrabianD, ComingsD, SellersEM,TyndaleRF,George SR,ODowdBF, UhlGR(2000)Human dopamine transporter gene: coding region conservation among normal, Tourettes disorder, alcohol dependence and attention-deficit hyperactivity disorder populations.Mol Psychiatry 5:283-292
206. Vandenbergh DJ, Bennett CJ, Grant MD, Strasser AA, OConnor R, Stauffer RL, Vogler GP, Kozlowski LT (2002) Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. Nicotine Tob Res 4:333-340
207. Verrico C, Miller GM, Madras BK (2005) MDMA (ecstasy) and human dopamine, norepinephrine and serotonin transporters: implications for MDMA-Induced neurotoxicity and treatment. Psychopharmacology (Berl) 12:1-15
208. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C (1998) Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776
209. Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N, Hahn F, Herpertz- Dahlmann B, Gossler M, Fleischhaker C, Schulz E, Hebebrand J, Warnke A, Hinney A (2004) Transmission disequilibriumstudies in children and adolescents with obsessivecompulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm 111:817-825
210. Wernicke C, Smolka M, Gallinat J, Winterer G, Schmidt LG, Rommelspacher H (2002) Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neurosci Lett 333:45-48
211. Winsberg BG, Comings DE (1999) Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J AmAcad Child Adolesc Psychiatry 38:1474-1477
212. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3:465-471
213. Xu X, Knight J, Brookes K,Mill J, Sham P, Craig I, Taylor E, Asherson P (2005) DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association. AmJMed Genet BNeuropsychiatr Genet 134:115-118
214. Yang L, Wang YF, Li J, Faraone SV (2004) Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry 43:1154-1158
215. YeoA, BoydP, LumsdenS,SaundersT,HandleyA,StubbinsM,KnaggsA,AsquithS, Taylor I, Bahari B, Crocker N, Rallan R,Varsani S,Montgomery D, Alpers DH, Dukes GE, Purvis I, Hicks GA (2004) Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 53:1452-1458
216. Zalsman G, Frisch A, Bromberg M, Gelernter J, Michaelovsky E, Campino A, Erlich Z, Tyano S, Apter A,Weizman A (2001) Family-based association study of serotonin transporter promoter in suicidal adolescents: no association with suicidality but possible role in violence traits. Am J Med Genet 105:239-245
217. Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A 98:1982-1987
218. Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Muller-Siecheneder F, Zwanzger P, Schule C, Minov C, Behrens S, Rupprecht R, Hegerl U, Moller HJ, Bondy B (2002) Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 26:489-493